Avid Bioservices Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2024	2023	2022	2021	2020	2019 - 1994
Net Income	-140.75	0.26	127.67	3.32	-15.15	Upgrade
Depreciation & Amortization	11.11	7.21	4.48	3.45	3.09	Upgrade
Share-Based Compensation	9.73	10.98	7.38	3.85	2.5	Upgrade
Other Operating Activities	130.87	-31.17	-130.07	12.66	10.7	Upgrade
Operating Cash Flow	10.95	-12.72	9.47	31.18	5.83	Upgrade
Operating Cash Flow Growth	-	-	-69.65%	435.13%	-	Upgrade
Capital Expenditures	-31.81	-77.8	-56.41	-9.86	-3.81	Upgrade
Investing Cash Flow	-31.81	-77.8	-56.41	-9.86	-3.81	Upgrade
Share Issuance / Repurchase	1.4	3.41	3.36	36.13	1.12	Upgrade
Debt Issued / Paid	18.67	-0.51	-0.16	121.16	4.3	Upgrade
Other Financing Activities	-	-	-	-44.95	-4.33	Upgrade
Financing Cash Flow	20.07	2.9	3.2	112.34	1.1	Upgrade
Net Cash Flow	-0.79	-87.62	-43.75	133.65	3.11	Upgrade
Free Cash Flow	-20.85	-90.53	-46.95	21.32	2.02	Upgrade
Free Cash Flow Growth	-	-	-	957.97%	-	Upgrade
Free Cash Flow Margin	-14.90%	-60.65%	-39.25%	22.24%	3.38%	Upgrade
Free Cash Flow Per Share	-0.33	-1.45	-0.76	0.37	0.04	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).